Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5) (HY060033)

价格:

规格：

50ug
100ug
1mg

数量：

一键复制产品信息

概述
图片
参考文献
产品说明书

HY060033

abinScience

种属反应性

Human

ELISA, FuncS, SPR

IgG2a, kappa

F7, Coagulation factor VII, FVII, Proconvertin, Serum prothrombin conversion accelerator, SPCA, Eptacog alfa, mutant version of FVIIa, FVIIaDVQ, Vatreptacog alfa, hFVIIa, rFVIIa analog NN1731

内毒素水平

Please contact with the lab for this information.

>95% as determined by SDS-PAGE.

Protein A/G purified from cell culture supernatant.

Accession号

P08709

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Antibody (4F5) (abinScience Cat# HY060033, RRID:AB_3727168)

Liquid

0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

产品使用信息

应用方法	稀释比例
ELISA	1:2000-1:20000

稳定性和存储

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Vatreptacog alfa

Coagulation factor VII (FVIIa Mutant Version (FVIIaDVQ)) is a ~51 kDa protein. Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa also converts factor IX to factor IXa in the presence of tissue factor and calcium.

1. Osterud, B. et al. (1977) Proceedings of the National Academy of Sciences of the United States of America 74, 5260-4. PMID: 271951

For research use only.

SDS-PAGE

SDS-PAGE for Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Antibody (4F5)

产品说明书

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5).pdf

质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)

填写 质量、浓度、体积中的任意 2 项 + 分子量，自动计算未知值。

分子量 *

g/mol

C₁ × V₁ = C₂ × V₂

填写 4 项中的任意 3 项，自动计算未知值。

C₁ (起始浓度)

V₁ (起始体积)

C₂ (终浓度)

V₂ (终体积)

重组蛋白

抗体

试剂盒

实验相关试剂

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5) (HY060033)

概述

图片

参考文献

产品说明书

相关产品推荐

重组蛋白

抗体

试剂盒

实验相关试剂

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5) (HY060033)

概述

图片

参考文献

产品说明书

相关产品推荐

获取报价